Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa

ClinicalTrials.gov ID: NCT01910155

Public ClinicalTrials.gov record NCT01910155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension (Par) Compared to CIPRODEX® (Ciprofloxacin 0.3%/Dexamethasone 0.1%) Sterile Otic Suspension (Alcon) in the Treatment of Adults With Acute Bacterial Otitis Externa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to compare the relative efficacy and safety of the test formulation of ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension (Par Pharmaceutical Companies, Inc.) to the already-marketed formulation CIPRODEX® (ciprofloxacin 0.3%/dexamethasone 0.1%) sterile otic suspension (Alcon) in the treatment of acute bacterial otitis externa.

Study identification

NCT ID
NCT01910155
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Par Pharmaceutical, Inc.
Industry
Enrollment
455 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2013 (Type not available)
Primary completion
Feb 2015 (Actual)
Completion
Mar 2015 (Actual)
Last update posted
Oct 18, 2016

2013 – 2015

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
James Donivan Gordon, MD Tucson Arizona 85745 —
Nea Baptist Clinic Jonesboro Arkansas 72401 —
Applied Reserch Center Little Rock Arkansas 72212 —
John Champlin, MD Carmichael California 95608 —
Aliance Research Long Beach California 90813 —
ENT of South Florida Boyton Beach Florida 33426 —
Moore Clinical Research Inc Fort Myers Florida 33919 —
Jorge Diaz, MD Hialeah Florida 33016 —
San Marcus Research Clinic Miami Florida 33015 —
The Medical Consulting Center Miami Florida 33125 —
Ormond Medical Arts Pharmaceutical Research Center Ormond Beach Florida 32174 —
Winter Park Clinical Research Winter Park Florida 32792 —
Research Integrity, LLC Owensboro Kentucky 42303 —
Pioneer Clinical Research Bellevue Nebraska 68005 —
PMG Research of Raleigh Raleigh North Carolina 27609 —
PMG Research of Salisbury Salisbury North Carolina 28144 —
Julia Mullen, MD Cincinnati Ohio 45246 —
Integrated Medical Research PC Ashland Oregon 97520 —
Cyn3rgy Gresham Oregon 97030 —
Peak Research LLC Upper Saint Clair Pennsylvania 15241 —
John Ansley, MD Orangeburg South Carolina 29118 —
Spartanburg and Geer ENT Spartanburg South Carolina 29303 —
Monica Davis, MD Brentwood Tennessee 37027 —
Gilbert Ledesma, MD Arlington Texas 76012 —
West Houston Clinical Research Service Houston Texas 77055 —
R-D Clinical Research Lake Jackson Texas 77566 —
The Education and Research Foundation Inc. Lynchburg Virginia 24501 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01910155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 18, 2016 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01910155 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →